2-chloro-1-(furan-2-yl)ethan-1-one, 95.0%, 250mg

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one, 95.0%, 100mg

2-[2-(Dicyclohexylphosphino)phenyl]-1-methyl-1H-indole, 97%, 250mg

2-amino-6-methoxypyridine-3,5-dicarbonitrile, 95.0%, 250mg

3-Iodo-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine hydrochloride, 98%, 100mg

Luminol sodium salt hemihydrate, min. 98%, pa, 1 g, glass packaging

7-Benzyl-1,7-diazaspiro[4.5]decane, 95%, 100mg

(S)-tert-Butyl (1-amino-3-(4-bromophenyl)-1-oxopropan-2-yl)carbamate, 98%, 100mg

tert-Butyl 3-bromo-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate, 95.0%, 25g

1-Methyl-4-(6-nitropyridin-3-yl)piperazine, 95.0%, 250mg

bScope BS.1153-PLPHi for phase contrast. Triocular with HWF 10x/20 mm eyepieces and quintuple revolver E-plan Phase IOS 10/20/S40 S100x

{[(3,4-dichlorophenyl)methyl]sulfanyl}methanimidamide hydrobromide, 95.0%, 2g

6-CHLORO-8-METHYL-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE, 95.0%, 1g